As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of HilleVax, Inc. - Common Stock (HLVX). This represents 0% of the company’s total 49,862,069 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$82,472,983 | $2.09 | 0 |
| 2025 Q2 | 41,482,960 | $82,475,168 | -$1,148,009 | $1.99 | 73 |
| 2025 Q1 | 42,159,649 | $61,462,501 | -$803,616 | $1.45 | 81 |
| 2024 Q4 | 42,837,211 | $88,691,412 | -$1,922,815 | $2.07 | 76 |
| 2024 Q3 | 41,746,872 | $73,514,766 | -$125,350,056 | $1.76 | 79 |
| 2024 Q2 | 45,490,986 | $657,609,131 | +$17,178,106 | $14.46 | 91 |
| 2024 Q1 | 43,902,279 | $730,023,644 | +$27,469,011 | $16.63 | 80 |
| 2023 Q4 | 42,260,488 | $678,283,363 | +$2,078,184 | $16.05 | 69 |
| 2023 Q3 | 34,134,471 | $459,257,248 | +$117,952,601 | $13.45 | 68 |
| 2023 Q2 | 25,405,469 | $436,645,635 | -$15,432,144 | $17.19 | 54 |
| 2023 Q1 | 26,409,127 | $436,246,966 | +$31,686,995 | $16.53 | 61 |
| 2022 Q4 | 26,312,441 | $440,207,224 | +$21,738,018 | $16.73 | 55 |
| 2022 Q3 | 23,399,373 | $399,913,116 | -$7,528,050 | $17.09 | 50 |
| 2022 Q2 | 23,224,867 | $253,676,000 | +$253,676,000 | $10.93 | 54 |